The daily daily use of high-CBD, low-THC cannabis extracts is safe and effective in treating symptoms related to pediatric movement disorders, according to a study published in the Journal of Child Neurology.
According to researchers, “A complex motor disorder is a combination of various types of abnormal movements that are associated with impaired quality of life (QOL).” Given that “Current therapeutic options are limited”, the researchers “studied the efficacy, safety, and tolerability of medical cannabis in children with complex motor disorder.”
For the pilot study, which was approved by the institutional ethics committee, “Two products of cannabidiol (CBD) enriched 5% oil formulation of cannabis were compared: one with 0.25% δ-9-tetrahydrocannabinol (THC) 20:1 group, the other with 0.83% THC 6:1 group.” Patients aged 1 to 17 years with complex motor disorder were enrolled. The assigned medication was administered for 5 months.
“Significant improvement in spasticity and dystonia, sleep difficulties, pain severity, and QOL was observed in the total study cohort, regardless of treatment assignment”, states the study’s abstract.” Adverse effects “were rare.”
More information on this study can be found by clicking here.